Table 4 HLA-DRB1 allele frequency in patients with ESRD and controls.
From: Associations between end stage renal disease and HLA polymorphisms in the Guangxi Zhuang population
ESRD (2n = 650) | Control (2n = 700) | P | Pc | OR | 95% CI | |||
|---|---|---|---|---|---|---|---|---|
NO. | AF (%) | NO. | AF (%) | |||||
15:01 | 109 | 16.77 | 102 | 14.57 | 0.267 | NS | 1.181 | 0.880–1.585 |
14:54 | 102 | 15.69 | 74 | 10.57 | 0.005 | NS | 1.575 | 1.143–2.169 |
16:02 | 70 | 10.77 | 110 | 15.71 | 0.008 | NS | 0.647 | 0.470–0.892 |
12:02 | 60 | 9.23 | 41 | 5.86 | 0.019 | NS | 1.635 | 1.082–2.469 |
03:01 | 56 | 8.62 | 76 | 10.86 | 0.166 | NS | 0.774 | 0.538–1.113 |
15:02 | 44 | 6.77 | 74 | 10.57 | 0.013 | NS | 0.614 | 0.416–0.907 |
04:05 | 36 | 5.54 | 27 | 3.86 | 0.143 | NS | 1.461 | 0.877–2.436 |
09:01 | 29 | 4.46 | 48 | 6.86 | 0.058 | NS | 0.634 | 0.395–1.019 |
11:01 | 28 | 4.31 | 22 | 3.14 | 0.257 | NS | 1.387 | 0.785–2.450 |
13:12 | 26 | 4.00 | 34 | 4.86 | 0.445 | NS | 0.816 | 0.484–1.376 |
14:05 | 18 | 2.77 | 12 | 1.71 | 0.189 | NS | 1.633 | 0.780–3.417 |
07:01 | 13 | 2.00 | 14 | 2.00 | 1.000 | NS | 1.000 | 0.466–2.144 |
10:01 | 10 | 1.54 | 16 | 2.29 | 0.318 | NS | 0.668 | 0.301–1.483 |
04:03 | 9 | 1.38 | 5 | 0.71 | 0.224 | NS | 1.952 | 0.651–5.854 |
14:04 | 9 | 1.38 | 9 | 1.29 | 0.874 | NS | 1.078 | 0.425–2.733 |
08:03 | 8 | 1.23 | 12 | 1.71 | 0.462 | NS | 0.714 | 0.290–1.759 |
12:01 | 5 | 0.77 | 5 | 0.71 | 1.000 | NS | 1.078 | 0.311–3.739 |
04:06 | 4 | 0.62 | 1 | 0.14 | 0.202 | NS | 4.328 | 0.483–38.825 |
13:02 | 3 | 0.46 | 8 | 1.14 | 0.164 | NS | 0.401 | 0.106–1.518 |
16:01 | 3 | 0.46 | 0 | 0 | NS | |||
11:06 | 2 | 0.31 | 2 | 0.29 | 1.000 | NS | 1.077 | 0.151–7.669 |
14:07 | 2 | 0.31 | 1 | 0.14 | 0.611 | NS | 2.157 | 0.195–23.849 |
04:04 | 1 | 0.15 | 2 | 0.29 | 1.000 | NS | 0.538 | 0.049–5.945 |
08:02 | 1 | 0.15 | 1 | 0.14 | 1.000 | NS | 1.077 | 0.067–17.255 |
14:03 | 1 | 0.15 | 0 | 0 | ||||
15:07 | 1 | 0.15 | 0 | 0 | ||||
